Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 280 participants.
Also called NCT07324031
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 280 participants
- Sponsor
- AtaCor Medical, Inc.
- Registry
-
NCT07324031
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Netherlands
- Registry status
- Recruiting
Technical summary
Registry record NCT07324031. Allocation not applicable; no masking; primary purpose treatment. Start 2026-07-02 (actual); primary completion 2027-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
- Acronym
- ALARION EV
- Condition
- Ventricular Arrythmia
- Condition
- Ventricular Fibrillation
- Condition
- Ventricular Tachycardia
- Intervention (Device)
- Atala™ lead and EV-ICD Pulse Generator
- Lead sponsor
- AtaCor Medical, Inc.
Record details
- Record id
cardio:ct-nct07324031- Content hash
15508e01e7bbe2ddc353fcb52d1de963ad0a15f5f652d6dd60e9fe63307a29f9